• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠溶包衣奥美拉唑胶囊药物释放的影响因素:比格犬体内外药代动力学研究及IVIVC评价

Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs.

作者信息

Cui Cheng, Sun Jiabei, Wang Xueqing, Yu Zhenxi, Shi Yaqin

机构信息

National Institutes for Food and Drug Control, Beijing, China.

Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.

出版信息

Dose Response. 2020 Mar 4;18(1):1559325820908980. doi: 10.1177/1559325820908980. eCollection 2020 Jan-Mar.

DOI:10.1177/1559325820908980
PMID:32180688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7057410/
Abstract

This study was performed to explore factors influencing the release of the proton pump inhibitor omeprazole from enteric-coated capsules in vitro and absorption in vivo in beagle dogs. Enteric-coated pellets with different enteric coating materials and coating levels were designed and prepared. All self-prepared formulations were characterized in vitro as well as in vivo and compared to the brand and generic commercial products. Evaluation of the corresponding release profiles suggested that coating material was the most critical factor. Enteric coating level determined the lag time before initiation of drug release, and subcoating level affected the drug release rate. Pharmacokinetic studies were performed in beagle dogs to further confirm the influence of formulation factors on drug absorption. Medium at pH 6.8 was a more biorelevant condition for in vitro drug release tests, although medium at pH 6.0 was better for discriminating release profiles of different formulations. A multiple level C in vitro/in vivo correlation was preliminarily established by which T and C of omeprazole formulations could be predicted with release parameters such as T and T. These results may facilitate quality evaluation and potentially improve the clinical efficacy of generic omeprazole products.

摘要

本研究旨在探讨影响质子泵抑制剂奥美拉唑肠溶胶囊体外释放及在比格犬体内吸收的因素。设计并制备了具有不同肠溶包衣材料和包衣水平的肠溶微丸。所有自制制剂均进行了体外和体内表征,并与品牌和仿制药商业产品进行了比较。对相应释放曲线的评估表明,包衣材料是最关键的因素。肠溶包衣水平决定了药物释放开始前的滞后时间,而底包衣水平影响药物释放速率。在比格犬身上进行了药代动力学研究,以进一步证实制剂因素对药物吸收的影响。pH 6.8的介质对体外药物释放试验来说是更具生物相关性的条件,尽管pH 6.0的介质更有利于区分不同制剂的释放曲线。初步建立了多级体外/体内相关性,据此可以用诸如T和T等释放参数预测奥美拉唑制剂的T和C。这些结果可能有助于质量评估,并有可能提高奥美拉唑仿制药产品的临床疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/51b0b6882c63/10.1177_1559325820908980-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/535ab7761baa/10.1177_1559325820908980-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/72d489034e20/10.1177_1559325820908980-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/16d0d64f6737/10.1177_1559325820908980-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/51b0b6882c63/10.1177_1559325820908980-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/535ab7761baa/10.1177_1559325820908980-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/72d489034e20/10.1177_1559325820908980-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/16d0d64f6737/10.1177_1559325820908980-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3014/7057410/51b0b6882c63/10.1177_1559325820908980-fig4.jpg

相似文献

1
Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs.肠溶包衣奥美拉唑胶囊药物释放的影响因素:比格犬体内外药代动力学研究及IVIVC评价
Dose Response. 2020 Mar 4;18(1):1559325820908980. doi: 10.1177/1559325820908980. eCollection 2020 Jan-Mar.
2
Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.含22.5%肠溶包衣微丸的20毫克奥美拉唑胶囊与参比产品在健康孟加拉国男性受试者中的生物利用度:一项开放标签、单剂量、随机序列、双向交叉研究。
Int J Clin Pharmacol Ther. 2011 Dec;49(12):778-86. doi: 10.5414/cp201569.
3
Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.升高 pH 值对商业肠溶包衣奥美拉唑微丸抗酸能力的影响:专利审查和仿制药比较
AAPS PharmSciTech. 2021 Jun 22;22(5):188. doi: 10.1208/s12249-021-02038-2.
4
In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.在生理碳酸氢盐缓冲液中用于儿科和老年患者的质子泵抑制剂产品的体外溶出度。
Int J Pharm. 2015 May 15;485(1-2):152-9. doi: 10.1016/j.ijpharm.2015.03.008. Epub 2015 Mar 5.
5
Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.使用碳酸氢盐缓冲系统对肠溶包衣质子泵抑制剂片剂进行溶出度表征。
J Pharm Pharmacol. 2016 Apr;68(4):467-74. doi: 10.1111/jphp.12540. Epub 2016 Mar 28.
6
Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.奥美拉唑多层膜包衣微丸的设计及体外/体内评价
Chem Pharm Bull (Tokyo). 2009 Feb;57(2):122-8. doi: 10.1248/cpb.57.122.
7
Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.开发一种用于设计缓释口服剂型的具有生理相关性的群体药代动力学体外-体内相关性方法。
Mol Pharm. 2017 Jan 3;14(1):53-65. doi: 10.1021/acs.molpharmaceut.6b00677. Epub 2016 Dec 12.
8
Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets.群体药代动力学与美沙拉嗪肠溶片的 IVIVC 研究
J Control Release. 2022 Jun;346:275-288. doi: 10.1016/j.jconrel.2022.04.024. Epub 2022 Apr 28.
9
Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.双氯芬酸钠肠溶包衣微丸的制剂及其体外和体内的生物利用度
Drug Dev Ind Pharm. 1998 Jul;24(7):661-6. doi: 10.3109/03639049809082368.
10
Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.开发一种仿生系统,用于同时预测肠溶制剂的释放/吸收特性。
Pharm Res. 2013 Feb;30(2):596-605. doi: 10.1007/s11095-012-0905-3. Epub 2012 Nov 8.

引用本文的文献

1
Enteric-coating film effect on the delayed drug release of pantoprazole gastro-resistant generic tablets.肠溶性包衣膜对泮托拉唑肠溶片延迟释放的影响。
F1000Res. 2023 Oct 12;12:1325. doi: 10.12688/f1000research.140607.1. eCollection 2023.
2
Flexible Coatings Facilitate pH-Targeted Drug Release via Self-Unfolding Foils: Applications for Oral Drug Delivery.柔性涂层通过自展开箔促进pH靶向药物释放:用于口服给药的应用。
Pharmaceutics. 2024 Jan 6;16(1):81. doi: 10.3390/pharmaceutics16010081.
3
Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT-1014-6470 in vitro and in vivo.

本文引用的文献

1
Optimized Synthesis of Biodegradable Elastomer PEGylated Poly(glycerol sebacate) and Their Biomedical Application.可生物降解弹性体聚乙二醇化聚癸二酸甘油酯的优化合成及其生物医学应用。
Polymers (Basel). 2019 Jun 3;11(6):965. doi: 10.3390/polym11060965.
2
Polyethylenimine-based Formulations for Delivery of Oligonucleotides.基于聚乙烯亚胺的寡核苷酸递药制剂。
Curr Med Chem. 2019;26(13):2264-2284. doi: 10.2174/0929867325666181031094759.
3
The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.
体外和体内评价补体因子 5a 受体 1 拮抗剂 ACT-1014-6470 对细胞色素 P450 2C19 和 3A4 的抑制潜力。
Clin Transl Sci. 2023 Jul;16(7):1220-1231. doi: 10.1111/cts.13525. Epub 2023 Apr 26.
4
Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics.兽医物种胃肠道差异对兽用治疗药物口服溶解度、体内溶出及制剂的影响。
ADMET DMPK. 2022 Feb 14;10(1):1-25. doi: 10.5599/admet.1140. eCollection 2022.
5
A prospective, randomized, masked, placebo-controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs.一项关于 10 毫克奥美拉唑胶囊对健康犬胃 pH 值影响的前瞻性、随机、双盲、安慰剂对照交叉研究。
J Vet Intern Med. 2021 Mar;35(2):887-891. doi: 10.1111/jvim.16061. Epub 2021 Feb 15.
使用固体剂型的品牌药与仿制药之间的差异:体外溶出度测试。
Results Pharma Sci. 2011 Dec 7;2:1-8. doi: 10.1016/j.rinphs.2011.12.001. eCollection 2012.
4
Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans.《动物农场:动物胃肠生理学考量及其与人类药物递送的相关性》
J Pharm Sci. 2015 Sep;104(9):2747-76. doi: 10.1002/jps.24365. Epub 2015 Feb 24.
5
Nanomedicine based on nucleic acids: pharmacokinetic and pharmacodynamic perspectives.基于核酸的纳米医学:药代动力学和药效学视角
Curr Pharm Biotechnol. 2014;15(9):829-38. doi: 10.2174/1389201015666141020155620.
6
Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.以 Eudragit® RL 和 L55 为基质的包衣:一种新型 pH 控制药物释放方法。
Int J Pharm. 2014 Dec 10;476(1-2):78-87. doi: 10.1016/j.ijpharm.2014.09.023. Epub 2014 Sep 17.
7
Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.模拟空腹状态下近犬胃肠道的溶解介质。
Eur J Pharm Biopharm. 2013 Aug;84(3):633-41. doi: 10.1016/j.ejpb.2013.01.010. Epub 2013 Feb 19.
8
A novel microsphere with a three-layer structure for duodenum-specific drug delivery.一种具有三层结构的新型微球,用于十二指肠特异性药物传递。
Int J Pharm. 2011 Jul 15;413(1-2):110-8. doi: 10.1016/j.ijpharm.2011.04.036. Epub 2011 Apr 21.
9
Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.在健康的孟加拉国男性志愿者中,两种不同的埃索美拉唑肠溶制剂的相对生物利用度和药代动力学特征:一项开放标签、单剂量、随机序列、两周期交叉研究。
Clin Ther. 2010 Jul;32(7):1419-26. doi: 10.1016/j.clinthera.2010.07.007.
10
A paradigm shift in enteric coating: achieving rapid release in the proximal small intestine of man.肠溶性包衣的范式转变:实现人体近端小肠的快速释放。
J Control Release. 2010 Oct 15;147(2):242-5. doi: 10.1016/j.jconrel.2010.07.105. Epub 2010 Jul 22.